October 28, 2016
Sun Pharma closing down Ocular Technologies buy for $40M plus royalties on its Dry Eye Disease drug (Seciera)
Sun Pharma with its subsidiaries agrees to buy 100% of Ocular Technologies
Pharmaceuticals, Biotechnology and Life Sciences
Sun Pharma with its subsidiaries agrees to buy 100% of Ocular Technologies